Edition:
United Kingdom

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,266
52-wk High
$4.09
52-wk Low
$1.86

Chart for

About

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in... (more)

Overall

Beta: 1.24
Market Cap(Mil.): $55.71
Shares Outstanding(Mil.): 15.39
Dividend: --
Yield (%): --

Financials

  EVOK.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.89 -- --
ROI: -230.38 15.07 14.61
ROE: -428.40 16.60 16.34

BRIEF-Evoke Pharma Granted Gender Specific Patent For Gimoti In Mexico

* EVOKE GRANTED GENDER SPECIFIC PATENT FOR GIMOTI™ IN MEXICO Source text for Eikon: Further company coverage:

10 May 2018

BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments

* EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS

26 Mar 2018

BRIEF-Evoke Pharma Q4 Loss Per Share $0.02

* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

07 Mar 2018

Earnings vs. Estimates